Fortress Biotech Files Q1 2025 10-Q
Ticker: FBIOP · Form: 10-Q · Filed: May 15, 2025 · CIK: 1429260
Sentiment: neutral
Topics: 10-Q, financials, biotech
Related Tickers: FBIO
TL;DR
**FBIO Q1 2025 10-Q filed: $34.3M assets, $2.8M liabilities. All systems go.**
AI Summary
Fortress Biotech, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $34.3 million and total liabilities of $2.8 million for the quarter. Fortress Biotech, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with a snapshot of Fortress Biotech's financial health and operational status as of March 31, 2025, crucial for understanding its current market position.
Risk Assessment
Risk Level: medium — The company operates in the pharmaceutical sector, which is inherently risky due to research and development costs, regulatory hurdles, and market competition.
Key Numbers
- $34.3M — Total Assets (As of March 31, 2025)
- $2.8M — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- Fortress Biotech, Inc. (company) — Filer
- March 31, 2025 (date) — Reporting Period End Date
- Delaware (location) — State of Incorporation
- $34.3 million (dollar_amount) — Total Assets
- $2.8 million (dollar_amount) — Total Liabilities
FAQ
What were Fortress Biotech's total assets as of March 31, 2025?
Fortress Biotech's total assets were $34,271,380 as of March 31, 2025.
What were Fortress Biotech's total liabilities as of March 31, 2025?
Fortress Biotech's total liabilities were $2,790,883 as of March 31, 2025.
What is Fortress Biotech's fiscal year end?
Fortress Biotech's fiscal year ends on December 31.
In which state is Fortress Biotech, Inc. incorporated?
Fortress Biotech, Inc. is incorporated in Delaware.
What is the filing date for this 10-Q report?
This 10-Q report was filed on May 15, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Fortress Biotech, Inc. (FBIOP).